Enanta Pharmaceuticals (ENTA) Tax Rate Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.00 |
| Dec 31, 2025 | -32.00 |
| Sep 30, 2025 | -12.00 |
| Jun 30, 2025 | -155.00 |
| Dec 31, 2024 | 171.00 |
| Sep 30, 2024 | 14,717.00 |
| Jun 30, 2024 | -2,638.00 |
| Mar 31, 2024 | 2,554.00 |
| Dec 31, 2023 | -2,651.00 |
| Sep 30, 2023 | 6,224.00 |
| Jun 30, 2023 | -4,548.00 |
| Mar 31, 2023 | -3,961.00 |
| Dec 31, 2022 | -995.00 |
| Sep 30, 2022 | 553.00 |
| Jun 30, 2022 | 1,543.00 |
| Dec 31, 2021 | -1,242.00 |
| Sep 30, 2021 | -16,884.00 |
| Jun 30, 2021 | 1,270.00 |
| Mar 31, 2021 | -5,435.00 |
| Dec 31, 2020 | 458.00 |
| Sep 30, 2020 | -2,389.00 |
| Jun 30, 2020 | 6,611.00 |
| Mar 31, 2020 | 7,930.00 |
| Dec 31, 2019 | 3,371.00 |
| Sep 30, 2019 | 2,585.00 |
| Jun 30, 2019 | -8,164.00 |
| Mar 31, 2019 | -200,931.00 |
| Dec 31, 2018 | 3,964.00 |
| Sep 30, 2018 | -1,536.00 |
| Jun 30, 2018 | -612.00 |
| Mar 31, 2018 | 7,100.00 |
| Dec 31, 2017 | 6,418.00 |
| Sep 30, 2017 | -3,262.00 |
| Jun 30, 2017 | -7,604.00 |